Continue to content

Symposium on Diagnostics and Response Monitoring in Acute Leukemia in 2024

Discover the provisional program and register now!

01 June 2024 - 01 June 2024

Hof ter Musschen

Avenue E. Mounier 2, 1200 Brussels

Organised by
BHS

* This event is not open to nurses and industry (except sponsors of this event).

Programme

The BHS Acute Leukemia Committee is pleased to invite hematologists, but also clinical and molecular biologists to to their symposium on "Diagnostics and Response Monitoring in Acute Leukemia in 2024" to be held on Saturday, 1 June in Hof ter Musschen (Brussels)*

Check out the final program below and register now!

9:30 Welcome

9:35 Case Presentation - A Devoeght (CHU de Liège)

9:50 Acute Leukemia work-up: are we in a hurry? - F. Andreozzi (HUB Jules Bordet)

10:20 The role of new techniques in diagnostics - Elly De Vlieghere (AZ Sint-Jan Brugge)

10:50 Coffee break

11:20 Case Presentation

11:35 Quality program for molecular MRD monitoring - E. Linskens (UZ Brussel)

12:05 Flow MRD monitoring (and implementation of AI) - M. Hofmans (UZ Gent)

12:35 Flow vs molecular MRD - B Depreter (AZ Roeselare/VUB)

13:00 Lunch break

14:00 The role of MRD in non-intensive treatment regimens for AML - R. Dillon (King's College, UK)

14:30 The role of MRD in non-intensive treatment regimens for ALL - P. Rousselot (Université de Versailles, France)

15:00 Is MRD negativity the goal or can we do better? - P. Lewalle (HUB Institut Jules Bordet)

15:30 ALLtogether: what can we learn from pediatric ALL? - V. Mondelaers (UZ Gent)

16:00 Close

This event is made possible thanks to our valued industry partners

  • 40th General Annual Meeting of the Belgian Hematology Society 2025

    7/02/2025 - 8/02/2025
    Dolce La Hulpe Brussels
  • POST-ASH 2025

    17/01/2025 - 17/01/2025
    Sheraton Brussels Airport HotelJoin us at the next edition of the POST-ASH to be held on Friday, 17 January at the Sheraton Brussels…
  • BHS Webinar supported by Lilly

    19/12/2024 - 19/12/2024
    How to improve care of MCL patients in the future: The big debate – Pros & Cons